Veterinary Medicines

PULMOTIL AC 250 mg/ml, concentrat pentru soluție orală

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
PULMOTIL AC 250 mg/ml, concentrat pentru soluție orală
Active substance:
  • Tilmicosin
Target species:
  • Pig
  • Cattle (calf)
  • Chicken (hen)
  • Turkey
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Tilmicosin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for oral solution
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Pig
      • Meat and offal
        14
        day
    • Cattle (calf)
      • Meat and offal
        42
        day
    • Chicken (hen)
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        19
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 190224
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 22/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."